Thursday, June 25, 2020 10:02:47 AM
New found alliance? LOL we knew it century ago.
At $0.37 per share, and a roughly $260 million MC today. Is this not cheap enough?
Now looking forward
Data lock by end of next week
Topline data by end of next month
By a margin, you are free to move around these goal posts some days further. Regardless, there will be a rude awakening for a lot of heads when all are done soon.
The blinded data just need to be confirmed to be equally good if not better. Then
FDA has no way but to usher in a new age of how cancers will be treated with a new generation, paradigm shift immunotherapeutic cancer vaccines spearheaded by Northwest Bio's DCvax platform.
There is a risk of course, but it is worthy of taking. Many still have the pipe dream to get in cheap when things turn out to be what expected with regard to trial data.
At this point, the usual fearmongers like dilution, financing, and the like don't work any more.
At $0.37 per share, and a roughly $260 million MC today. Is this not cheap enough?
Now looking forward
Data lock by end of next week
Topline data by end of next month
By a margin, you are free to move around these goal posts some days further. Regardless, there will be a rude awakening for a lot of heads when all are done soon.
The blinded data just need to be confirmed to be equally good if not better. Then
FDA has no way but to usher in a new age of how cancers will be treated with a new generation, paradigm shift immunotherapeutic cancer vaccines spearheaded by Northwest Bio's DCvax platform.
There is a risk of course, but it is worthy of taking. Many still have the pipe dream to get in cheap when things turn out to be what expected with regard to trial data.
At this point, the usual fearmongers like dilution, financing, and the like don't work any more.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
